Depression
Depressive disorders are characterised by low mood or loss of interest in pleasurable activities accompanied by other cognitive, behavioural or physical symptoms that significantly impact ability to function (1). In children and young people depression can present with more prominent irritability than low mood (2).
NICE (3) highlights the variation in presenting symptoms and severity of depression and describes the continuum of depression as comprising 3 elements:
-
Symptoms – which can vary in frequency and intensity
-
Duration of the disorder
-
The impact on personal and social functioning
Severity of depression is therefore a consequence of the contribution of all of these elements.
Depressive disorders are usually episodic, with most people recovering with treatment and support, but can also be recurring or persistent (1), (4). Chronic or persistent depression (also known as dysthymia) is defined as the presence of a major depressive episode for the duration of at least 2 years, or the presence of persistent low mood for more than 2 years or a combination or both. Additionally, people with chronic or persistent depression experience significant impairment in their personal, interpersonal and social functioning. Depression can also be linked to long-term physical health problems including cancer, heart disease, diabetes, and physical disabilities from stroke, respiratory disease, kidney disease, chronic pain such as arthritis, or multiple sclerosis (5). These conditions can be distressing and difficult to cope with, may compromise mental health, and may culminate in depression (3). Depression has been identified as the most relevant risk factor for suicide and is strongly related to both suicidal ideation and attempt (3),(6),(7).
Practitioners treating individuals with depression should always aim to build a trusting relationship with the individuals and their families, as they work in an open, engaging, and non-judgemental manner to explore treatment options. Additionally, practitioners should recognise different causes of depression and be aware that stigma and discrimination can be associated with the presentation and diagnosis of depressive disorder (3). Discussions about the individual’s diagnosis, treatment, and support should take place in settings in which confidentiality, privacy and dignity are respected (3).
Prevalence of depression in children and young people is approximately 1-2% for pre-pubertal children, rising in early teens (more steeply for girls than boys) to 4-5% for mid-teens (8). The rates of raised depressive symptoms (or subthreshold depression) is much higher in adolescence with estimated 34% prevalence (9)
Depression is common in adults. The exact prevalence of depression varies depending on social situation, age, presence of comorbidities and the severity of depression experienced. In people aged 18-44 years, depression is the leading cause of disability and premature death, with a worldwide prevalence of 4.4%, and a UK prevalence of 4.5% (3). According to the Scottish Health Survey 2022, the proportion of adults in Scotland with two or more symptoms of depression was 13% for all adults, which is an increase in prevalence from an earlier survey in 2010/11 (prevalence was 7% among men(10) and 9% among women). Lower prevalence of symptoms of depression was recorded among people aged 75 and over at 7%, prevalence for 65-74 age group was 9% (11). More than 50% of people experiencing a major depressive episode recover within 6 months, and nearly 75% within a year (3). In the longer-term, the proportion of people who recover drops to approximately 60% at 2 years, 40% at 4 years, and 30% at 6 years (3). With treatment, the majority of depressive episodes last about 3–6 months (3). All treatments including talking therapies as well as prescribed medication offer a range of benefits and costs in terms of side effects and the best options for an individual should be discussed openly, allowing individuals to understand and consider their own treatment decisions.
There are challenges in estimating prevalence rates of depression in people with intellectual disability, as studies vary in methodology and the application of diagnostic criteria. Mental health presentations may also differ compared to those without intellectual disability. Reported prevalence of depression in people with intellectual disability varies with a range of 3- 15% in adults across all levels of intellectual disability (12) and estimates of 4% in adults with mild intellectual disability (13) prevalence of depression in children and young people with all levels of intellectual disability is 2% (12).
This information is for commissioners, managers, trainers, and health care practitioners to consider the evidence base for the delivery of psychological interventions for people with depression. This information is also for people diagnosed with depression, their families, and carers.
This topic introduction page covers evidence-based psychological interventions used to treat depression in children, young people, and adults, and the psychological practice/settings in which these interventions can be delivered. Depression commonly presents with other conditions, e.g. anxiety, substance use, PTSD and physical illness. The Matrix pages related to these topics may also be relevant.
Exclusions for topic: This topic does not cover pharmacological interventions or interventions which are not informed by psychological theory. There are a wider range of non-psychological interventions and supports that are beyond the scope of this topic and full guidance on best practice can be found in NICE guidance (2),(3).
There are a range of psychological interventions that could be included in the treatment tables for depression. However, in order to be consistent with a focus on interventions with the highest levels of efficacy and the strongest levels of evidence where these exist, psychological interventions for the treatment of depression with low strength evidence and low levels of efficacy have not been included.
Evidence of overview for children and young people (CYP)
High quality evidence demonstrates that psychological interventions are effective for depression in children and young people (14). A stepped approach to care can be adopted in the management of CYP with depression. This approach takes into consideration the different needs of CYP with depression and the responses needed from health and social care services (2). However, decisions on the psychological intervention offered can also be guided by several factors, including severity of depression, patient and family’s capacity to access care, their clinical needs, developmental level and child and parent preferences (2). Options are listed in relation to new presentations of less severe depression (mild, subthreshold or dysthymia), more severe depression (moderate to severe) and chronic or comorbid depression.
Less severe depression
Children and young people with mild depression (without significant comorbid problems or active suicidal ideas or plans) can be offered digital/computerised formats of cognitive–behavioural therapy (CBT), group CBT, group interpersonal psychotherapy (IPT) or group non-directive supportive therapy as first line recommendation (2). As mentioned above, choice of intervention should be guided by several factors and delivered in line with the principles for delivering-effective-psychological-therapies-and-interventions-to-children-and-young-people. Individual CBT and attachment-based family therapy are also recommended as alternative interventions. In a stepped care model these would be applied if needs were not met by the digital or group recommendations. The ability and wish to engage with computerised CBT, group or individual treatment approaches will vary with age and preference.
More severe depression
Children and young people with moderate to severe depression can be offered interventions adapted to developmental level. In 5- to 11-year-olds family-based IPT, family therapy (family-focused treatment for childhood depression and systems integrated family therapy), psychodynamic psychotherapy and individual CBT are recommended. In 12 to 18 year olds individual CBT is recommended as a first line intervention. If individual CBT is unsuitable for the adolescent due to clinical needs, personal choice or circumstances then IPT for adolescents, family therapy (attachment based or systemic), psychodynamic psychotherapy, behavioural activation or brief psychosocial intervention can be alternatives.
The evidence for psychological interventions in younger children is based on fewer trials than in adolescents. There is a risk of bias in many trials on which the evidence is based with one meta-analysis finding 20% meeting all quality criteria in an analysis of 40 studies (14). More studies involve CBT and IPT than the other treatment options. Group delivery format is more common in trials than individual treatment.
CBT can be delivered in several formats (including individual, group and face-to-face) with medium-large effect sizes (15),(16). Specific CBT intervention components - including cognitive work and behavioural activation can improve outcomes (15), as well taking into account the individual contextual and developmental needs (2). These factors can be considered when decisions are made regarding the content and context of delivery.
IPT can be delivered in group and individual format and a meta-analysis examining changes in depression symptoms post intervention revealed a large significant improvement in depression symptoms following IPT for adolescents (17),(18).
Lastly, NICE guidance for the management of depression in CYP includes recommendations for family therapies - family-focused treatment for childhood depression (FFT-CD) (2), (19),(20) and systems integrated family therapy in 5–11-year-olds as a first line option. In 12–18-year-olds family therapies are an alternative recommendation (attachment based or systemic) (2),(21) These recommendations have been based on a smaller number of trials.
One moderate quality RCT reported similar outcomes of Attachment-Based Family Therapy (ABFT) when compared to Family Enhanced Non-Directive Supportive Therapy (FE-NST) for reducing adolescents’ suicide ideation and depressive symptoms (21) and a meta-analyses which compared ABFT with other approaches found similar effects across family therapy approaches, and no statistically significant effect of family therapy approaches over other approaches such as IPT or CBT (22).
Treatment choices should be based on individual circumstances, clinical history and presentation, presence of co-existing neurodevelopmental disorders, learning disabilities or comorbidities, as well as patient and carer preferences (23). Interventions delivered should be adapted to developmental level as needed (23). Not all treatment options may be currently available in every setting. Family/caregiver involvement can improve treatment outcomes for CYP with depression and practitioners should involve the family where appropriate. However, the circumstances and form of involvement that are most associated with engagement and improvement are not yet fully determined (24).
Chronic or comorbid depression
Adolescents experiencing chronic or comorbid depression may benefit from combined treatment with psychological therapies and antidepressants (2). Monitoring to establish the benefits of both elements can be clinical helpful and the need for medication should be reviewed as per prescribing guidelines. Comorbid problems, such as anxiety, are common and the relevant Matrix topics should be consulted as appropriate.
Overview of evidence for adults
A collaborative approach to care should be considered in the management of people with depression. Pathways provided should promote access to care, choice, coordination and continuity of care, and facilitate integrated care delivery across services (3).
A range of treatments have proven efficacy, including pharmacological and other interventions such as exercise, which go beyond the scope of this guidance (see NICE, 2022 for a full review). The psychological intervention offered can depend on several factors including severity of depression, the patient’s capacity to access care, their clinical needs, and preferences (3). Options are listed in relation to new presentations of less severe depression (mild or subthreshold); new episodes of more severe depression (moderate and severe range) and for chronic depressive symptoms.
It should be noted that estimates of response rates across psychological interventions are around 40% (25) and response to interventions should be monitored and an alternative approach offered if required. Additionally, psychological therapy can be combined with an antidepressant medication.
Interventions are listed in an order reflecting their clinical and cost-effectiveness for differing presentations of depression.
Less severe depression:
Individuals with less severe depression whose needs and preferences match with a psychological intervention can be offered: Guided self-help, Group cognitive behavioural therapy (CBT), Group behavioural activation (BA), Individual CBT, Individual BA, Group mindfulness (such as mindfulness based cognitive therapy), Interpersonal psychotherapy (IPT), Person Centred Experiential Counselling for Depression (PCECfD), Short-term psychodynamic psychotherapy (short-term PP).
More severe depression:
Individuals with more severe depression whose needs and preferences match with a psychological intervention can be offered: Individual CBT (with or without antidepressant medication), Individual BA, Individual problem solving, Person Centred Experiential Counselling for Depression (PCECfD), Short-term psychodynamic psychotherapy (short-term PP), IPT or Guided self-help.
Guided self-help varies in format from books to digital formats, such as apps and online programmes. There is evidence of greater effects and stronger adherence when delivered with support from an appropriately trained health care professional (26),(27), (28), (29),(30),(31),(32). Guided self-help interventions for the treatment of new episodes of less severe and more severe depression should involve printed or digital self-help materials based on CBT, structured BA, problem-solving or psychoeducation materials and should involve support from a trained facilitator who encourages progress (3). It usually consists of 6-8 regular structured sessions. Guided self-help can have comparable effects in the treatment of depression as face-to-face treatments with a low to moderate effect on symptoms (33).
Groups can be a cost-effective option for treatment of less severe depression. CBT, BA and Mindfulness based groups are recommended (3) with small-large impacts on symptoms. The group delivery should be provided by a practitioner who has therapy-specific training and competence, preferably supported by second practitioner. Groups should typically include 8 regular sessions. Clinicians might consider the required balance of number of sessions. Higher numbers of sessions provide access to additional content and may aid group cohesion. However, longer courses may cause increased drop-out. Research is required to discover the best balance of length and duration as how this relates to individual patient choice.
Individual CBT, BA, IPT, short-term PP and Person-Centred Experiential Counselling for Depression (PCECfD), are recommended for new episodes of depression across different levels of severity. In addition, Individual problem-solving can be considered for more severe depression. They should be delivered by a practitioner with therapy-specific training and competence and should follow an empirically validated protocol or treatment manual specifically for depression. Duration typically consists of 8-16 regular sessions and there is evidence that weekly or bi-weekly can have stronger effects (27) (16). These approaches have a well-established evidence base. There are some differences in effect sizes between interventions and trials (CBT – medium-high; BA- medium to high; problem solving therapy medium-high; IPT – medium (33) short-term PP -small; non-directive supportive therapy – medium (27),(16) and these can be taken into account alongside other factors, such as preference and availability.
Behavioural Couples Therapy (BCT) can be considered for a subgroup of adults with less or more severe depression who have problems in the relationship with their partner(3). These include adults for whom their relationship problem(s) could potentially be contributing to their depression, or partner involvement could assist with their treatment (3). BCT typically involves 15-20 sessions. The evidence for this approach is more limited than for the other interventions (3),(34) and this is included as an alternative recommendation in the evidence table.
Overview of evidence for older adults
A series of reviews suggest that psychological interventions are also effective in late-life depression (35) (36),(37) and evidence is especially well established for CBT and problem-solving therapy(35) and there is some evidence supporting efficacy for lower intensity interventions like guided self-help (38). The evidence is less well established for older people with depression who reside in long-term care where it is suggested that CBT, behavioural therapy and reminiscence therapy may reduce depressive symptoms and improve quality of life and psychological well-being in the short term (39). Clinicians are advised that there are differences in presentation of psychological problems in later life and to consult Delivering Psychological Therapies and Interventions for Older People for further information on factors relevant to practice.
Chronic or comorbid depression:
People may present with chronic depressive symptoms that may have not sought treatment for depression previously or may require further line treatment due to limited response to treatment or relapse. NICE guidelines recommend offering CBT (with or without an SSRI) to people who have not had previous treatment. CBT is effective for treatment resistant depression that has not responded to antidepressants (40). The CBT should have a focus on the chronic depressive symptoms and address key maintaining factors, i.e. avoidance, interpersonal problems, and rumination. If people have received previous treatment, or are currently not responding to therapy, then NICE recommend switching to another psychological therapy.
Large scale reviews of psychotherapies for depression include trials of chronic and treatment resistant depression and generally suggest that a combination of psychotherapy and medication is more effective than either alone (41), (27). These reviews, and others focusing on chronic depression include: CBT that focuses on chronic depression symptoms, including CBASP, specifically developed to treat chronic depression (42), (43),(44) IPT, and Mindfulness-based Cognitive Therapy (MBCT). MBCT can be considered for individuals with recurrent depressive disorder who are at high risk of relapse as a relapse prevention intervention. Meta-analytic studies have previously found MBCT to be most beneficial for relapse prevention in individuals who have experienced at least 3 previous depression episodes (45)(46). However, more recent work indicates a similar benefit in increasing time to relapse compared with treatment as usual however many previous episodes of depression there have been (47). MBCT also shows statistically significant improvement in suicidal ideation compared with treatment as usual (48). Effects seem to persist for at least six months after treatment (49). A smaller systematic review of 14 trials investigated the impact of psychological therapies on functioning and quality of life in persistent depression (50) found the impact highest for MBCT, IPT and psychodynamic psychotherapy with more variable findings in the impact of CBASP on functioning and QOL.
It is also common for people to experience depression in the context of other mental or physical health problems. The Matrix guidance for anxiety disorders, PTSD, substance use, personality disorder, mental health problems in the perinatal period and physical health topics should be considered as required. Collaborative care can be particularly helpful for older people with depression, those with significant physical health problems, social isolation or people with chronic depression not responding to usual specialist care (3).
Patients with severe depressive illness may experience psychotic symptoms. Psychological treatments can be offered after improvement in acute psychotic symptoms and can be combined with antidepressant medication and antipsychotic medication (3).
Overview of evidence for people with learning disabilities
Large scale trials of psychological interventions in general populations tend to exclude people with learning disabilities, therefore there is limited evidence for mental health interventions with this group. For people with learning disabilities and mental health difficulties, (51) recommend that general guidelines for psychological interventions should be considered, with appropriate adaptations for people with learning disabilities. More information relating to adapting therapy can be found on Delivering effective psychological therapies and interventions to people with Intellectual/Learning Disabilities (content under development).
For the treatment of depression NICE recommends CBT with appropriate adaptations for people with mild learning disabilities. A meta-analysis (52) CBT for adults with intellectual disability found a significant effect of controlled trials for depression, although most studies involve people with mild learning disabilities. The Mental Ill Health report from SLDO (2022) (1) conducted a rapid review to build on NICE. For people with mild or moderate learning disabilities, one RCT demonstrated efficacy for both Beat It (an adapted behavioural activation intervention) and Step Up (guided self-help) for depressive symptoms (53). Both interventions involve a supporter for the person with a learning disability. The evidence in people with severe and profound learning disabilities related to depression is too underdeveloped to result in recommendations for standalone psychological interventions.
Overview of evidence for harms and adverse effects
Like pharmaceutical treatments, psychological therapies also have the potential to have adverse effects. Until recently, information on potential harms and rates of adverse effects have not been gathered systematically in trials of psychological interventions for depression. Risks might include dependency on the therapist, risks of therapist abuse, or feeling worse as a result of assessment, or treatment awakening areas of distress before learning the skills to self-manage this.
One area that has been examined is the risk of deterioration in adult patients receiving psychological therapy for depression. This has been examined in a meta-analysis of 18 studies (54). This is a small proportion of all psychotherapy trials, and the majority do not report deterioration rates, thus the conclusions drawn should be considered with caution. The findings indicate that psychological treatments may reduce the risk of deterioration with a 61% lower chance to deteriorate than patients in control groups. However, clinicians should still be aware of the risk of deterioration during therapy (4-10% across studies).
Recommendation |
Who for? |
Intervention |
Type of Psychological Practice |
Evidence |
Efficacy |
First line |
Children and young people (5-18) with mild depression |
Digital cognitive–behavioural therapy (CBT)(2), (55)(56)(57)(58) |
Skilled/enhanced/specialist |
A |
low- medium |
Group CBT (2),(59),(27) |
Enhanced/specialist |
Medium -high |
|||
Group non-directive supportive therapy (NDST) (2) |
Enhanced |
N/A |
|||
Group interpersonal psychotherapy (IPT). (59)(2)(55) (17) (18) |
Specialist |
Medium-high |
|||
Alternative (if indicated by need or insufficient response to first line options) |
Children and young people (5-18) with mild depression |
Attachment-based family therapy (ABFT)(2),(21),(22) |
Specialist |
A
|
low-medium
|
Individual CBT. (2),(15),(55),(14) |
Specialist |
Medium- high |
|||
Young people (12-18) with mild depression |
Behavioural Activation for adolescents (4), (60) |
Enhanced/Specialist |
B |
low |
|
First line |
Children (5-11) with moderate to severe depression |
Family-based IPT(2) |
Specialist |
A |
low-medium(14) |
Family therapy (family-focused treatment for childhood depression and systems integrated family therapy) (2),(19),(22) |
|||||
Psychodynamic psychotherapy(2) |
|||||
Individual CBT(2) |
|||||
First line |
Young people (12-18) with moderate to severe depression |
Individual CBT (2) (14)(15) |
Specialist |
A |
|
First line |
CYP with mild to moderate learning disabilities and depression |
CBT (or specific components of CBT) with appropriate adaptations to needs based on formulation(51) |
Specialist |
C |
N/A |
Parent training programmes specifically designed for parents or carers of children with learning disabilities to help prevent or treat mental health problems in the child, and to support carer wellbeing (51) |
Enhanced/specialist |
B |
N/A |
||
Alternative |
Young people (12-18) with moderate to severe depression |
IPT for adolescents (2),(17) |
Enhanced/specialist |
A
|
High low-medium
|
Family therapy (attachment based or systemic) (2),(21),(22) |
|||||
Psychodynamic psychotherapy (2) |
|||||
Brief psychosocial intervention (2) |
|||||
Behavioural Activation (4), (60) |
B |
||||
First line |
CYP with chronic depression or co-occurring mental health difficulties |
Therapy combined with antidepressants (2) |
Enhanced/specialist |
A |
Low-high |
Recommendation |
Who for? |
Intervention |
Type of psychological intervention |
Evidence |
Efficacy |
First line |
Adults presenting with a new episode of less severe depression |
Guided Self-help (3), (25),(28), (61) |
Skilled/Enhanced |
A |
Low -high
|
Group CBT (3),(62)(27) |
Enhanced/Specialist |
||||
Group BA(63) (62), |
Enhanced/Specialist |
||||
Individual CBT (25), (16), (64) |
Specialist |
||||
Individual BA (16),(62), (65),(63) |
Enhanced/Specialist |
||||
Group mindfulness (such as mindfulness based cognitive therapy) (3) |
Enhanced/Specialist |
||||
Interpersonal psychotherapy (33)(3),(5) |
Specialist |
||||
Person Centred Experiential Counselling for Depression (PCECfD) (3) |
Enhanced/Specialist |
||||
Short-term PP (3),(66),(67) |
Specialist |
||||
First line |
Adults presenting with a new episode of more severe depression |
Individual CBT (with antidepressant medication) (27), (16) |
Specialist |
A |
Low-high |
Individual CBT (without antidepressants) (25) |
Specialist |
||||
Individual BA (16),(62), (65),(63) |
Enhanced/Specialist |
||||
Individual problem solving(3)(68) |
Enhanced/Specialist |
||||
Person Centred Experiential Counselling for Depression (PCECfD), (3) |
Enhanced/Specialist |
||||
Short-term PP (3),(66),(67) |
Specialist |
||||
IPT (3),(33) |
Specialist |
||||
Guided self help (25),(3),(61) |
Skilled/Enhanced |
||||
Alternative |
Adults with depression and a partner willing to participate in treatment |
Behavioural couples therapy (3),(34) |
Enhanced/Specialist |
A |
N/A |
First line |
Adults with chronic depression |
As above for severe depression Combination psychological therapy and medication |
Enhanced/Specialist |
A |
Low-high |
Alternative |
Adults with chronic depression |
MBCT (47),(49),(48) Group DBT (69) CBASP (42),(44) |
Enhanced/Specialist |
A |
Low-high |
First line |
Adults with mild to moderate learning disability and depression |
CBT (with appropriate adaptations to needs based on formulation) (52),(51) |
Specialist |
A |
N/A |
Alternative |
Adults with mild to moderate learning disability and depression |
Adapted Behavioural Activation (Beat It) Guided self-help (Step Up) (53) |
Enhanced/Specialist |
B |
N/A |
Co-occurring problems and depression |
|
Collaborative or multi-disciplinary care (3). This is common, please see other tables as appropriate. |
|
|
With thanks to Professor Chris Williams and SAM-H for their feedback and comments.
Technical group: Fiona Duffy, Alisdair Forrest, Patricia Graham, Allyson McDougall, Marina McLoughlin, Suzanne Mills, Leeanne Nicklas, Marie Claire Shankland, Fiona Switzer, Massimo Tarsia, Amanda Whyte.
1.World Health Organisation. ICD-11. 2019.
2.Overview | Depression in children and young people: identification and management | Guidance | NICE. 2019; Available at: https://www.nice.org.uk/guidance/ng134. Accessed Dec 17, 2024.
3.National Institute for Health and Care Excellence (NICE). Depression in adults: treatment and management. National Institute for Health and Care Excellence (NICE) 2022.
4.Tindall L., MikockaWalus A., McMillan D., Wright B., Hewitt C., Gascoyne S. Is behavioural activation effective in the treatment of depression in young people? A systematic review and meta-analysis. Psychology and psychotherapy 2017;90(4):770–796.
5.Read JR, Sharpe L, Modini M, Dear BF. Multimorbidity and depression: A systematic review and meta-analysis. Journal of Affective Disorders 2017 -10-15;221:36–46.
6.Bachmann S. Epidemiology of Suicide and the Psychiatric Perspective. International Journal of Environmental Research and Public Health 2018 /7;15(7):1425.
7.Brådvik L. Suicide Risk and Mental Disorders. International Journal of Environmental Research and Public Health 2018 /9;15(9):2028.
8.Maughan B, Collishaw S, Stringaris A. Depression in childhood and adolescence. J Can Acad Child Adolesc Psychiatry 2013 -02;22(1):35–40.
9.Shorey, S., Ng, E.D. and Wong, C.H.J. Global prevalence of depression and elevated depressive symptoms among adolescents: A systematic review and meta-analysis. British Journal of Clinical Psychology 2022 Sept 26;61(2):287–306.
10.Scottish Government: Population Health Directorate. The Scottish Health Survey 2022 – volume 1: main report. 2023 Dec 5:1.
11.Scottish Government: Public Health Directorate. The Scottish Health Survey 2022: summary report. 2023 Dec 5:1.
12.NICE. Overview | Mental health problems in people with learning disabilities: prevention, assessment and management | Guidance | NICE. 2016; Available at: https://www.nice.org.uk/guidance/ng54. Accessed Dec 19, 2024.
13.Royal College of Psychiatrists. Mental health services for adults with mild intellectual disability. 2020 March.
14.Cuijpers P, Karyotaki E, Ciharova M, Miguel C, Noma H, Stikkelbroek Y, Weisz JR, Furukawa TA. The effects of psychological treatments of depression in children and adolescents on response, reliable change, and deterioration: a systematic review and meta-analysis. European Child & Adolescent Psychiatry 2023 Jan:177–192.
15.Oud M, de Winter L, VermeulenSmit E, Bodden D, Nauta M, Stone L, et al. Effectiveness of CBT for children and adolescents with depression: A systematic review and meta-regression analysis. European Psychiatry 2019;57:33–45.
16.Cuijpers P, Karyotaki E, Harrer M, Stikkelbroek Y. Full article: Individual behavioral activation in the treatment of depression: A meta analysis. Psychotherapy Research 2015 Apr.
17.Duffy F SH, Schwannauer, M. Review. The effectiveness of interpersonal psychotherapy for adolescents with depression - a systematic review and meta-analysis. 2019 Nov 1:307–317.
18.Pu J, Zhou X, Liu L, Zhang Y, Yang L, Yuan S, et al. Efficacy and acceptability of interpersonal psychotherapy for depression in adolescents: A meta-analysis of randomized controlled trials. Psychiatry Research 2017 -07-01;253:226–232.
19.Tompson MC, Langer DA, Asarnow JR. Development and efficacy of a family-focused treatment for depression in childhood. Journal of Affective Disorders 2020 -11-01;276:686–695.
20.Asarnow JR, Tompson MC, Klomhaus AM, Babeva K, Langer DA, Sugar CA. Randomized controlled trial of family-focused treatment for child depression compared to individual psychotherapy: one-year outcomes. J Child Psychol Psychiatry 2020 -06;61(6):662–671.
21.Diamond GS, Kobak RR, Krauthamer Ewing ES, Levy SA, Herres JL, Russon JM, et al. A Randomized Controlled Trial: Attachment-Based Family and Nondirective Supportive Treatments for Youth Who Are Suicidal. J Am Acad Child Adolesc Psychiatry 2019 -07;58(7):721–731.
22.van Aswegen T., Samartzi E., Morris L., van der Spek N., de Vries R., Seedat S., et al. Effectiveness of family-based therapy for depressive symptoms in children and adolescents: A systematic review and meta-analysis. International journal of psychology : Journal international de psychologie 2023;58(6):499–511.
23.Herrman H, Patel V, Kieling C, Berk M, Buchweitz C, Cuijpers P, et al. Time for united action on depression: a Lancet–World Psychiatric Association Commission. The Lancet 2022 -03-05;399(10328):957–1022.
24.Dippel, N, Szota, K, Cuijpers, P, et al. Family involvement in psychotherapy for depression in children and adolescents: Systematic review and meta-analysis. Psychology and Psychotherapy:Theory, Research and Practice 2022 Mar 14;95(3):656–679.
25.Cuijpers P, Quero S, Noma H, Ciharova M, Miguel C, Karyotaki E, et al. Psychotherapies for depression: a network meta-analysis covering efficacy, acceptability and long-term outcomes of all main treatment types. World Psychiatry 2021 -06;20(2):283–293.
26.Ünlü B, Riper H, van Straten A, Cuijpers P. Guided self-help on the internet for turkish migrants with depression: the design of a randomized controlled trial. Trials 2010 November 4;11(1):101.
27.Cuijpers P, Miguel C, Harrer M, Plessen CY, Ciharova M, Papola D, et al. Psychological treatment of depression: A systematic overview of a ‘Meta-Analytic Research Domain’. Journal of Affective Disorders 2023 -08-15;335:141–151.
28.Cuijpers P., Donker T., Johansson R., Mohr D.C., van Straten A., Andersson G. Self-guided psychological treatment for depressive symptoms: A meta-analysis. PLoS ONE 2011;6(6) (pagination):Article Number: e21274. Date of Publication: 2011.
29.Cuijpers P, Kleiboer AM editors. Chapter: Self-directed approaches to the treatment of depression. : DeRubeis, Robert J [Ed]; Strunk, Daniel R [Ed]. (2017). The Oxford handbook of mood disorders. (pp. 469-477). xix, 514 pp. New York, NY, US: Oxford University Press; US; 2017.
30.Ebert DD, Lehr D, Boß L, Riper H, Cuijpers P, Andersson G, et al. Efficacy of an internet-based problem-solving training for teachers: results of a randomized controlled trial. Scand J Work Environ Health 2014 -11;40(6):582–596.
31.Kleiboer A, Donker T, Seekles W, van Straten A, Riper H, Cuijpers P. A randomized controlled trial on the role of support in Internet-based problem solving therapy for depression and anxiety. Behav Res Ther 2015 -09;72:63–71.
32.Warmerdam L, Straten Av, Twisk J, Riper H, Cuijpers P. Internet-Based Treatment for Adults with Depressive Symptoms: Randomized Controlled Trial. Journal of Medical Internet Research 2008 -11-20;10(4):e1094.
33.Cuijpers P. Interpersonal psychotherapy for depression: A meta-analysis (American Journal of Psychiatry). Am J Psychiatry 2011;168(6):652.
34.Barbato A, D'Avanzo B, Parabiaghi A. Couple therapy for depression. Cochrane Database of Systematic Reviews 2018(6).
35.Cuijpers P, Karyotaki E, Pot AM, Park M, Reynolds CF. Managing depression in older age: psychological interventions. Maturitas 2014 -10;79(2):160–169.
36.Cuijpers P, Karyotaki E, Eckshtain D, Ng MY, Corteselli KA, Noma H, et al. Psychotherapy for Depression Across Different Age Groups: A Systematic Review and Meta-analysis. JAMA Psychiatry 2020 -07-01;77(7):694–702.
37.Cuijpers P, van Straten A, Smit F, Andersson G. Is psychotherapy for depression equally effective in younger and older adults? A meta-regression analysis. Int Psychogeriatr 2009 -02;21(1):16–24.
38.Wuthrich VM, Dickson SJ, Pehlivan M, Chen JT-, Zagic D, Ghai I, et al. Efficacy of low intensity interventions for geriatric depression and anxiety - A systematic review and meta-analysis. J Affect Disord 2024 -01-01;344:592–599.
39.Davison TE, Bhar S, Wells Y, Owen PJ, You E, Doyle C, et al. Psychological therapies for depression in older adults residing in long-term care settings. Cochrane Database Syst Rev 2024 -03-19;3(3):CD013059.
40.Wiles NJ, Thomas L, Turner N, Garfield K, Kounali D, Campbell J, et al. Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: Follow-up of the CoBalT randomised controlled trial. The Lancet Psychiatry 2016;3(2):137–144.
41.Cuijpers P., Noma H., Karyotaki E., Vinkers C.H., Cipriani A., Furukawa TA. A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression. World Psychiatry 2020;19(1):92–107.
42.Jobst A, Brakemeier E-, Buchheim A, Caspar F, Cuijpers P, Ebmeier KP, et al. European Psychiatric Association Guidance on psychotherapy in chronic depression across Europe. European Psychiatry 2016 /03;33(1):18–36.
43.Schramm E, Kriston L, Zobel I, Bailer J, Wambach K, Backenstrass M, et al. Effect of Disorder-Specific vs Nonspecific Psychotherapy for Chronic Depression: A Randomized Clinical Trial. JAMA Psychiatry 2017 -03-01;74(3):233–242.
44.Schramm E, Kriston L, Elsaesser M, Fangmeier T, Meister R, Bausch P, et al. Two-year follow-up after treatment with the cognitive behavioral analysis system of psychotherapy versus supportive psychotherapy for early-onset chronic depression. Psychotherapy and Psychosomatics 2019;88(3):154–164.
45.Piet J, Hougaard E. The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis. Clin Psychol Rev 2011 -08;31(6):1032–1040.
46.Chiesa A, Serretti A. Mindfulness based cognitive therapy for psychiatric disorders: a systematic review and meta-analysis. Psychiatry Res 2011 -05-30;187(3):441–453.
47.McCartney M, Nevitt S, Lloyd A, Hill R, White R, Duarte R. Mindfulness-based cognitive therapy for prevention and time to depressive relapse: Systematic review and network meta-analysis. Acta Psychiatr Scand 2021 -01;143(1):6–21.
48.Zhang B, Fu W, Guo Y, Chen Y, Jiang C, Li X, et al. Effectiveness of mindfulness-based cognitive therapy against suicidal ideation in patients with depression: A systematic review and meta-analysis. J Affect Disord 2022 -12-15;319:655–662.
49.Cladder-Micus MB, Vrijsen JN, Fest A, Spijker J, Donders ART, Becker ES, et al. Follow-up outcomes of Mindfulness-Based Cognitive Therapy (MBCT) for patients with chronic, treatment-resistant depression. J Affect Disord 2023 -08-15;335:410–417.
50.McPherson S, Senra H. Psychological treatments for persistent depression: A systematic review and meta-analysis of quality of life and functioning outcomes. Psychotherapy 2022;59(3):447–459.
51.NICE 2016. Overview | Mental health problems in people with learning disabilities: prevention, assessment and management | Guidance | NICE. 2016; Available at: https://www.nice.org.uk/guidance/ng54. Accessed Dec 20, 2024.
52.Graser J, Göken J, Lyons N, Ostermann T, Michalak J. Cognitive-behavioral therapy for adults with intellectual disabilities: A meta-analysis. Clinical Psychology: Science and Practice 2022;29(3):227–242.
53.Jahoda A, Hastings R, Hatton C, Cooper S, Dagnan D, Zhang R, et al. Comparison of behavioural activation with guided self-help for treatment of depression in adults with intellectual disabilities: a randomised controlled trial. Lancet Psychiatry 2017 -12;4(12):909–919.
54.Cuijpers P, Reijnders M, Karyotaki E, de Wit L, Ebert DD. Negative effects of psychotherapies for adult depression: A meta-analysis of deterioration rates. J Affect Disord 2018;239:138–145.
55.Zhou X, Hetrick SE, Cuijpers P, Qin B, Barth J, Whittington CJ, et al. Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: A systematic review and network meta-analysis. World Psychiatry 2015 June 1;14(2):207–222.
56.Wickersham A, Barack T, Cross L, Downs J. Computerized Cognitive Behavioral Therapy for Treatment of Depression and Anxiety in Adolescents: Systematic Review and Meta-analysis. Journal of Medical Internet Research 2022 -04-11;24(4):e29842.
57.Liang J.H., Li J., Wu R.K., Li J.Y., Qian S., Jia R.X., et al. Effectiveness comparisons of various psychosocial therapies for children and adolescents with depression: a Bayesian network meta-analysis. European Child and Adolescent Psychiatry 2021;30(5):685–697.
58.National Institute for Health and Care Excellence. Guided self-help digital cognitive behavioural therapy for children and young people with mild to moderate symptoms of anxiety or low mood: early value assessment. 2023 , February 8.
59.Cuijpers P, Pineda BS, Ng MY, Weisz JR, Muñoz RF, Gentili C, et al. A Meta-analytic Review: Psychological Treatment of Subthreshold Depression in Children and Adolescents. J Am Acad Child Adolesc Psychiatry 2021 -09;60(9):1072–1084.
60.Tindall L., Kerrigan P., Li J., Hayward E., Gega L. Is behavioural activation an effective treatment for depression in children and adolescents? An updated systematic review and meta-analysis. European Child and Adolescent Psychiatry 2024;33(12) (pp 4133-4156):Article Number: e100100. Date of Publication: 01 Dec 2024.
61.Andrews G., Cuijpers P., Craske M.G., McEvoy P., Titov N. Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: a meta-analysis. PloS one 2010;5(10):e13196.
62.Cuijpers P, Noma H, Karyotaki E, Cipriani A, Furukawa TA. Effectiveness and Acceptability of Cognitive Behavior Therapy Delivery Formats in Adults With Depression: A Network Meta-analysis. JAMA Psychiatry 2019 -07-01;76(7):700–707.
63.Richards DA, Ekers D, McMillan D, Taylor RS, Byford S, Warren FC, et al. Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial. Lancet 2016 -08-27;388(10047):871–880.
64.Cuijpers P, Miguel C, Harrer M, Plessen CY, Ciharova M, Ebert D, et al. Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta-analysis including 409 trials with 52,702 patients. World Psychiatry 2023 February 1;22(1):105–115.
65.Uphoff E., Ekers D., Robertson L., Dawson S., Sanger E., South E., et al. Behavioural activation therapy for depression in adults. Cochrane Database of Systematic Reviews 2020;2020(7) (pagination):Article Number: CD013305. Date of Publication: 06 Jul 2020.
66.Fonagy P, Rost F, Carlyle J, McPherson S, Thomas R, Pasco Fearon RM, et al. Pragmatic randomized controlled trial of long-term psychoanalytic psychotherapy for treatment-resistant depression: the Tavistock Adult Depression Study (TADS). World Psychiatry 2015 October 1;14(3):312–321.
67.Cuijpers P, Karyotaki E, de Wit L, Ebert DD. The effects of fifteen evidence-supported therapies for adult depression: A meta-analytic review. Psychotherapy Research 2020 April 2;30(3):279–293.
68.Cuijpers P, de Wit L, Kleiboer A, Karyotaki E, Ebert DD. Problem-solving therapy for adult depression: An updated meta-analysis. Eur Psychiatry 2018 -02;48:27–37.
69.Ijaz S, Davies P, Williamsa CJ, Kessler D, Lewis G, Wiles N. Psychological therapies for treatment‐resistant depression in adults. Cochrane Database of Systematic Reviews 2018(5).